BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Breast cancer AND SMAD4, JIP, Q13485, 4089, ENSG00000141646, MADH4, DPC4 AND Diagnosis
16 results:

  • 1. Immunohistochemical Characterization of a Large Cohort of Triple Negative breast cancer.
    Han R; Nofech-Mozes S; Boles D; Wu H; Curcin N; Slodkowska E
    Int J Surg Pathol; 2024 Apr; 32(2):239-251. PubMed ID: 37306115
    [No Abstract]    [Full Text] [Related]  

  • 2. Clinico-genomic Characterization of ATM and HRD in Pancreas cancer: Application for Practice.
    Park W; O'Connor CA; Bandlamudi C; Forman D; Chou JF; Umeda S; Reyngold M; Varghese AM; Keane F; Balogun F; Yu KH; Kelsen DP; Crane C; Capanu M; Iacobuzio-Donahue C; O'Reilly EM
    Clin Cancer Res; 2022 Nov; 28(21):4782-4792. PubMed ID: 36040493
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Prediction of Upstaging in Ductal Carcinoma in Situ Based on Mammographic Radiomic Features.
    Hou R; Grimm LJ; Mazurowski MA; Marks JR; King LM; Maley CC; Lynch T; van Oirsouw M; Rogers K; Stone N; Wallis M; Teuwen J; Wesseling J; Hwang ES; Lo JY
    Radiology; 2022 Apr; 303(1):54-62. PubMed ID: 34981975
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Evaluation of biomarkers, genetic mutations, and epigenetic modifications in early diagnosis of pancreatic cancer.
    Rah B; Banday MA; Bhat GR; Shah OJ; Jeelani H; Kawoosa F; Yousuf T; Afroze D
    World J Gastroenterol; 2021 Sep; 27(36):6093-6109. PubMed ID: 34629822
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Pancreatic acinar cell carcinoma with a ductal adenocarcinoma component: a case report and analysis of the histogenesis of the tumor.
    Kimura T; Tabata S; Togawa T; Onchi H; Iida A; Sato Y; Goi T
    World J Surg Oncol; 2020 Sep; 18(1):238. PubMed ID: 32891173
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Clinical and Histologic Overlap and Distinction Among Various Hamartomatous Polyposis Syndromes.
    Gilad O; Rosner G; Fliss-Isakov N; Aharon-Kaspi S; Strul H; Gluck N; Kariv R
    Clin Transl Gastroenterol; 2019 May; 10(5):1-9. PubMed ID: 31107726
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Diffusion of digital breast tomosynthesis among women in primary care: associations with insurance type.
    Clark CR; Tosteson TD; Tosteson ANA; Onega T; Weiss JE; Harris KA; Haas JS
    Cancer Med; 2017 May; 6(5):1102-1107. PubMed ID: 28378409
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Geographic variation in the intended choice of adjuvant treatments for women diagnosed with screen-detected breast cancer in Queensland.
    Hsieh JC; Cramb SM; McGree JM; Dunn NA; Baade PD; Mengersen KL
    BMC Public Health; 2015 Dec; 15():1204. PubMed ID: 26630881
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. TIF1γ interferes with TGFβ1/smad4 signaling to promote poor outcome in operable breast cancer patients.
    Kassem L; Deygas M; Fattet L; Lopez J; Goulvent T; Lavergne E; Chabaud S; Carrabin N; Chopin N; Bachelot T; Gillet G; Treilleux I; Rimokh R
    BMC Cancer; 2015 Jun; 15():453. PubMed ID: 26040677
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. The utility of smad4 as a diagnostic immunohistochemical marker for pancreatic adenocarcinoma, and its expression in other solid tumors.
    Ali S; Cohen C; Little JV; Sequeira JH; Mosunjac MB; Siddiqui MT
    Diagn Cytopathol; 2007 Oct; 35(10):644-8. PubMed ID: 17854080
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Pathologic findings from the breast cancer Surveillance Consortium: population-based outcomes in women undergoing biopsy after screening mammography.
    Weaver DL; Rosenberg RD; Barlow WE; Ichikawa L; Carney PA; Kerlikowske K; Buist DS; Geller BM; Key CR; Maygarden SJ; Ballard-Barbash R
    Cancer; 2006 Feb; 106(4):732-42. PubMed ID: 16411214
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. breast cancer yield for screening mammographic examinations with recommendation for short-interval follow-up.
    Kerlikowske K; Smith-Bindman R; Abraham LA; Lehman CD; Yankaskas BC; Ballard-Barbash R; Barlow WE; Voeks JH; Geller BM; Carney PA; Sickles EA
    Radiology; 2005 Mar; 234(3):684-92. PubMed ID: 15734926
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Immunohistochemistry can help distinguish metastatic pancreatic adenocarcinomas from bile duct adenomas and hamartomas of the liver.
    Hornick JL; Lauwers GY; Odze RD
    Am J Surg Pathol; 2005 Mar; 29(3):381-9. PubMed ID: 15725808
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Biennial versus annual mammography and the risk of late-stage breast cancer.
    White E; Miglioretti DL; Yankaskas BC; Geller BM; Rosenberg RD; Kerlikowske K; Saba L; Vacek PM; Carney PA; Buist DS; Oestreicher N; Barlow W; Ballard-Barbash R; Taplin SH
    J Natl Cancer Inst; 2004 Dec; 96(24):1832-9. PubMed ID: 15601639
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Hamartomatous polyposis syndromes: molecular genetics, neoplastic risk, and surveillance recommendations.
    Wirtzfeld DA; Petrelli NJ; Rodriguez-Bigas MA
    Ann Surg Oncol; 2001 May; 8(4):319-27. PubMed ID: 11352305
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Association of poor prognosis with loss of 12q, 17p, and 18q, and concordant loss of 6q/17p and 12q/18q in human pancreatic ductal adenocarcinoma.
    Yatsuoka T; Sunamura M; Furukawa T; Fukushige S; Yokoyama T; Inoue H; Shibuya K; Takeda K; Matsuno S; Horii A
    Am J Gastroenterol; 2000 Aug; 95(8):2080-5. PubMed ID: 10950061
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.